Skip to main content
. 2024 Mar 8;10(1):29–37. doi: 10.1159/000538131

Table 2.

Associations between urinary biomarkers and risk of liver cancer, Southern community cohort study

Biomarker Overall Cases diagnosed <5 years from baseline Cases diagnosed ≥5 years from baseline
cases/controls OR (95% CI)a cases/controls OR (95% CI)a cases/controls OR (95% CI)a
PGE-M
 T1 (low) 16/49 1.00 (ref) 7/49 1.00 (ref) 9/49 1.00 (ref)
 T2 12/52 0.34 (0.09–1.33) 2/52 0.16 (0.02–1.69) 10/52 0.30 (0.05–1.70)
 T3 21/50 0.39 (0.10–1.45) 8/50 0.55 (0.08–4.00) 13/50 0.21 (0.04–1.26)
p for trend 0.44 0.47 0.18
PGD-M
 T1 (low) 16/50 1.00 (ref) 5/50 1.00 (ref) 11/50 1.00 (ref)
 T2 22/52 1.63 (0.57–4.64) 8/52 1.41 (0.25–7.96) 14/52 1.32 (0.37–4.64)
 T3 12/49 0.39 (0.11–1.44) 5/49 0.59 (0.07–4.67) 7/49 0.34 (0.07–1.67)
p for trend 0.99 0.06 0.06
PGI-M
 T1 (low) 10/50 1.00 (ref) 4/50 1.00 (ref) 6/50 1.00 (ref)
 T2 10/51 0.56 (0.14–2.26) 2/51 0.42 (0.03–5.69) 8/51 0.70 (0.13–3.68)
 T3 30/50 1.55 (0.40–6.12) 12/50 1.17 (0.11–12.42) 18/50 1.75 (0.32–9.68)
p for trend 0.12 0.28 0.06
11dTxB2
 T1 (low) 5/50 1.00 (ref) 2/50 1.00 (ref) 3/50 1.00 (ref)
 T2 10/49 4.08 (0.86–19.50) 2/49 2.94 (0.20–42.78) 8/49 6.58 (0.91–47.49)
 T3 35/50 11.50 (2.34–56.47) 14/50 14.21 (1.08–187.36) 21/50 12.02 (1.56–92.53)
p for trend 0.004 0.0005 0.009
TN-E
 T1 (low) 10/50 1.00 (ref) 5/50 1.00 (ref) 5/50 1.00 (ref)
 T2 21/51 1.70 (0.49–5.85) 8/51 0.65 (0.10–4.32) 13/51 6.16 (1.00–38.07)
 T3 19/50 1.30 (0.31–5.47) 5/50 0.26 (0.03–2.78) 14/50 5.69 (0.73–44.03)
p for trend 0.82 0.18 0.37

p for trend was calculated by including the biomarkers as continuous variables in the model.

aMultivariate logistic regression model adjusted for all of the five biomarker levels in tertiles, age, sex, race, BMI, smoking status, NSAID use, household income, education, and alcohol drinking status.